K-V Pharmaceutical (KV-A) Establishes Generic Marketing Subsidiary, Mark Hartman Named President
Tweet Send to a Friend
K-V Pharmaceutical Company (NYSE: KV-A) announced that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
